Novartis has inked a deal with Sironax that gives the pharma the exclusive option to acquire the biotech’s blood-brain ...

Sironax, a clinical-stage biotech company dedicated to the discovery and development of transformational therapies for age-related diseases, today announced a strategic agreement with Novartis under ...

Swiss drugmaker Novartis will keep making medicines for malaria and leprosy, even if it does not get orders as normal amid the global health funding crunch, its president of global health told ...

Novartis' gene-therapy efforts haven't moved as fast as expected, CEO Vas Narasimhan said. While it's turned one program into a blockbuster, Novartis has hit bumps in the road in other areas.